Form 4: Analog Devices CEO Exercises, Sells Shares

Analog Devices CEO Vincent Roche exercised stock options and subsequently sold 10,000 shares of common stock under a pre-arranged 10b5-1 plan.

Summary

• Vincent Roche, Chair & CEO of Analog Devices Inc. (ADI), reported transactions on February 2, 2026.
• Exercised 10,000 non-qualified stock options at an exercise price of $94.41 per share.
• Sold 10,000 shares of common stock at a price of $306.92 per share.
• The sale was executed pursuant to a Rule 10b5-1 plan adopted on May 23, 2025.
• Following these transactions, Roche directly owns 155,688.462 shares of common stock.
• Additionally, 23,515 shares are indirectly held by the Vincent Roche 2024 Grantor Retained Annuity Trust.
• Roche also beneficially owns 44,637 non-qualified stock options directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction, pre-planned under a 10b5-1 plan, which is a common practice for executive compensation and liquidity management. The sale is offset by the exercise of options, indicating a structured approach rather than a reactive divestment.

Positives

• The exercise of options indicates a prior grant of equity compensation, aligning management interests with shareholders.
• The transaction was pre-planned under a Rule 10b5-1 plan, indicating a structured approach to personal financial management rather than a reaction to immediate company news.

Negatives

• The sale of 10,000 shares by the CEO could be perceived by some investors as a reduction in direct ownership, although it is a common practice for liquidity and tax purposes, especially when exercising options.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under 10b5-1 plans, are a routine part of executive compensation and personal financial planning in the semiconductor industry. These pre-arranged plans help executives manage their equity holdings while avoiding accusations of trading on material non-public information.

Comparison to Industry Standards

• The use of a 10b5-1 plan for stock sales is a standard practice among executives in publicly traded companies, including peers like Intel, Qualcomm, and NVIDIA, to ensure compliance with insider trading regulations.
• The exercise of stock options is a common form of equity compensation, aligning with practices seen across the technology and semiconductor sectors.

Related Party Transactions

• 23,515 shares are indirectly held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024, which is a related party transaction for beneficial ownership reporting.

Stakeholder Impact

• Shareholders: The transaction represents a reduction in direct ownership by the CEO, which could be viewed neutrally given the 10b5-1 plan, or slightly negatively by some who prefer higher insider ownership. However, it also reflects the monetization of equity compensation.

Key Dates

Recommendation

The filing details a routine insider transaction involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. This is a common practice for executive compensation and personal financial planning and does not typically signal a change in the company's fundamental outlook or performance. Therefore, a 'hold' recommendation is appropriate as this specific filing provides no new information to alter an existing investment thesis.

Keywords

Analog Devices, ADI, Vincent Roche, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, CEO, Equity Compensation